Melvin L.K. Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation Oncology at National Cancer Centre Singapore, shared a post by Medical Channel Asia on LinkedIn, adding:
“Thanks for this feature by Medical Channel Asia that is a prelude to and part of the publicity for the upcoming ASCOBT26.
Thanks for American Society of Clinical Oncology (ASCO) for choosing Singapore as the venue for this meeting and looking forward to welcoming colleagues from the APAC region and the World for this year’s meeting this will focus on the following themes:
- Early detection and treatment of early cancers
- Precision medicine and new Omics AI approaches
- Equitable care and low cost innovations
- ClinicalTrials in Cancer.”
Quoting Medical Channel Asia’s post:
“Singapore is a global leader in cancer survival outcomes, but what makes their healthcare model so effective?
In this interview, Prof. Melvin L.K. Chua, Senior Consultant and Head of Department at the National Cancer Centre Singapore, discusses the intersection of cutting-edge technology, equitable access to care, and the unique challenges of treating cancer in Asian populations.”
Other Articles Featuring Melvin L.K. Chua on OncoDaily.